Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Paranasal Sinus Neoplasms 1Oropharyngeal Neoplasms 1Nasopharyngeal Neoplasms 1Mouth Neoplasms 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1

Interventions

Cisplatin 7Cetuximab 6Radiotherapy 5Fluorouracil 4Radiotherapy, Intensity-Modulated 3Docetaxel 3pembrolizumab 2Radiation 2Psychiatric Rehabilitation 2Nicotine 2Hydroxyurea 2Drug Therapy 2Counseling 2Celecoxib 2Bupropion 2sodium thiosulfate 1sargramostim 1motexafin gadolinium 1eniluracil 1durvalumab 1Zinc Oxide 1Varenicline 1Tobacco Use Cessation Devices 1Surgical Procedures, Operative 1Semaxinib 1Referral and Consultation 1Protons 1Proton Therapy 1Polymerase Chain Reaction 1Pilocarpine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hypopharyngeal Neoplasms × Chemoprevention × Clear all
NCT01469429 2020-02-20

Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.

Ohio State University Comprehensive Cancer Center

Phase 1/2 Completed
70 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Paranasal Sinus Neoplasms, Salivary Gland Neoplasms, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡